{"id":52004,"date":"2022-12-14T23:02:07","date_gmt":"2022-12-14T22:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/"},"modified":"2022-12-14T23:02:07","modified_gmt":"2022-12-14T22:02:07","slug":"fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/","title":{"rendered":"FDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test"},"content":{"rendered":"
\n

CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Applied Biosystems TaqPath Monkeypox\/Orthopox Virus DNA Kit, a polymerase chain reaction (PCR) test designed to detect non-variola Orthopoxviruses,<\/i> including monkeypox virus, in approximately three-and-a-half hours.\n<\/p>\n

<\/a><\/p>\n

\nThe test is intended for the qualitative detection of DNA from monkeypox virus (clade I\/II) and screening for non-variola Orthopoxviruses<\/i> in human lesion swab specimens from individuals suspected of monkeypox (mpox) infection by their healthcare provider.\n<\/p>\n

\nThe TaqPath Monkeypox\/Orthopox Virus DNA Kit is also designed for identification of other non-variola Orthopoxvirus<\/i> DNA. <\/i>While positive results are indicative of the presence of DNA from monkeypox virus or other non-variola Orthopoxvirus<\/i>, clinicians must correlate PCR results with patient history and other diagnostic information to determine infection status.\n<\/p>\n

\n\u201cEnsuring that all U.S. laboratories have access to monkeypox PCR testing is a critical part of the response to this public health emergency,\u201d said Manoj Gandhi, senior medical director for Genetic Testing Solutions, Thermo Fisher Scientific. \u201cThis helps expedite availability of results so that patients can receive the appropriate treatment quickly. Authorized testing also enables public health agencies to stay one step ahead of the virus by monitoring viral spread and addressing affected populations accordingly.\u201d\n<\/p>\n

\nIn early 2020, Thermo Fisher was among the first companies to distribute an emergency use authorized assay to identify active SARS-CoV-2 infections with the TaqPath COVID-19 Combo Kit<\/a>. The TaqPath Monkeypox\/Orthopox Virus DNA Kit builds off that technology and reflects Thermo Fisher\u2019s continued commitment to develop diagnostic tools designed to address pressing public health emergencies as soon as possible.\n<\/p>\n

\nFor more information on Thermo Fisher\u2019s infectious disease testing platform, please visit the website<\/a>.\n<\/p>\n

\nFor In Vitro Diagnostic Use. For Emergency Use Authorization Only; Rx Only\n<\/p>\n

\nAbout Thermo Fisher<\/b>\n<\/p>\n

\nThermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:
\n
Mauricio Minotta
\n
760-805-5266
\n
Mauricio.Minotta@thermofisher.com<\/a>\n<\/p>\n

\nAriane Lovell
\n
646-307-6317
\n
Ariane.lovell@finnpartners.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Applied Biosystems TaqPath Monkeypox\/Orthopox Virus DNA Kit, a polymerase chain reaction (PCR) test designed to detect non-variola Orthopoxviruses, including monkeypox virus, in approximately three-and-a-half hours. The test … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52004","6":"format-standard","7":"category-industry"},"yoast_head":"\nFDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Applied Biosystems TaqPath Monkeypox\/Orthopox Virus DNA Kit, a polymerase chain reaction (PCR) test designed to detect non-variola Orthopoxviruses, including monkeypox virus, in approximately three-and-a-half hours. The test ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-14T22:02:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221214005941\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"FDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test\",\"datePublished\":\"2022-12-14T22:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/\"},\"wordCount\":450,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221214005941\\\/en\\\/1387941\\\/21\\\/Thermo_Fisher_Scientific.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/\",\"name\":\"FDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221214005941\\\/en\\\/1387941\\\/21\\\/Thermo_Fisher_Scientific.jpg\",\"datePublished\":\"2022-12-14T22:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221214005941\\\/en\\\/1387941\\\/21\\\/Thermo_Fisher_Scientific.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221214005941\\\/en\\\/1387941\\\/21\\\/Thermo_Fisher_Scientific.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/","og_locale":"en_US","og_type":"article","og_title":"FDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test - Pharma Trend","og_description":"CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Applied Biosystems TaqPath Monkeypox\/Orthopox Virus DNA Kit, a polymerase chain reaction (PCR) test designed to detect non-variola Orthopoxviruses, including monkeypox virus, in approximately three-and-a-half hours. The test ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-14T22:02:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221214005941\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"FDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test","datePublished":"2022-12-14T22:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/"},"wordCount":450,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221214005941\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/","url":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/","name":"FDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221214005941\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg","datePublished":"2022-12-14T22:02:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221214005941\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221214005941\/en\/1387941\/21\/Thermo_Fisher_Scientific.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/fda-grants-emergency-use-authorization-for-thermo-fisher-scientifics-monkeypox-test\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"FDA Grants Emergency Use Authorization for Thermo Fisher Scientific\u2019s Monkeypox Test"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52004","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52004"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52004\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52004"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52004"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52004"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}